Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Buprenorphine
Drug ID BADD_D00310
Description Buprenorphine is a weak partial mu-opioid receptor agonist and a weak kappa-opioid receptor antagonist used for the treatment of severe pain.[A186283,A186292] It is also commonly used as an alternative to [methadone] for the treatment of severe opioid addiction.[F4715,F4718] Buprenorphine is commercially available as the brand name product Suboxone which is formulated in a 4:1 fixed-dose combination product along with [naloxone], a non-selective competitive opioid receptor antagonist. Combination with naloxone is intended to reduce the abuse potential of Suboxone, as naloxone is poorly absorbed by the oral route (and has no effect when taken orally), but would reverse the opioid agonist effects of buprenorphine if injected intravenously.[A186289,F4715,F4718] Buprenorphine has poor gastrointestinal absorption and is therefore formulated as a sublingual tablet.
Indications and Usage For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.
Marketing Status Prescription; Discontinued
ATC Code N02AE01; N07BC01
DrugBank ID DB00921
KEGG ID D07132
MeSH ID D002047
PubChem ID 644073
TTD Drug ID D06AWE
NDC Product Code 51927-0062; 12578-607; 65724-0050; 0093-3659; 71335-0353; 42858-586; 60687-492; 62756-460; 59011-750; 65267-203; 67509-003; 12496-0100; 60687-481; 42858-353; 69238-1203; 42858-501; 59011-758; 62756-459; 71335-1154; 12496-0300; 69238-1505; 38779-3255; 59011-751; 68071-2592; 59011-757; 50090-5805; 73548-1039; 0093-3657; 0792-0631; 59011-752; 71335-0950; 69238-1202; 69238-1204; 0228-3153; 42858-502; 49812-0239; 0093-3239; 70518-1625; 42858-750; 0093-3658; 42858-493; 42858-839; 71795-2200; 0093-3656; 10920-593; 0228-3156; 12707-036; 47848-030; 69238-1205
Synonyms Buprenorphine | Buprenex | Prefin | Subutex | Buprex | Temgesic | Temgésic | 6029-M | 6029 M | 6029M | RX-6029-M | RX 6029 M | RX6029M | Buprenorphine Hydrochloride | Hydrochloride, Buprenorphine
Chemical Information
Molecular Formula C29H41NO4
CAS Registry Number 52485-79-7
SMILES CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mental status changes19.07.01.001--Not Available
Mobility decreased17.02.05.018; 15.03.01.003; 08.01.03.0300.006505%Not Available
Energy increased08.01.03.0170.001859%Not Available
Peripheral swelling08.01.03.053; 02.05.04.015--Not Available
Abasia17.02.05.035; 08.01.02.007--Not Available
Cervical vertebral fracture15.08.05.002; 12.04.04.0030.001859%Not Available
Intervertebral disc protrusion15.10.01.0040.002788%Not Available
Contusion24.07.06.001; 23.03.11.002; 15.03.01.008; 12.01.06.0010.006505%
Eye pruritus06.04.05.0060.001859%Not Available
Pruritus generalised23.03.12.0030.013939%Not Available
Musculoskeletal stiffness15.03.01.005--Not Available
Musculoskeletal discomfort15.03.04.0010.001859%Not Available
Affect lability19.04.01.001--Not Available
Skin burning sensation23.03.03.021; 17.02.06.0090.006505%Not Available
Foetal death08.04.01.011; 18.01.02.0030.001455%
Hypoaesthesia oral07.05.05.003; 17.02.06.0210.001859%Not Available
Paraesthesia oral07.05.03.003; 17.02.06.0080.002788%Not Available
Cognitive disorder19.21.02.001; 17.03.03.003--
Staphylococcal infection11.02.05.0020.004646%Not Available
Hot flush08.01.03.027; 24.03.01.005; 21.02.02.0010.008363%
Feeding disorder19.09.01.003; 14.03.02.0030.001859%Not Available
Limb discomfort15.03.04.014--Not Available
Skin injury23.03.11.009; 12.01.06.0040.001859%Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Feeling of body temperature change08.01.09.0120.008363%Not Available
Erectile dysfunction21.03.01.007; 19.08.04.0010.003717%
Drug intolerance08.06.01.0130.018585%Not Available
Psychotic disorder19.03.01.002--
Renal impairment20.01.03.010--Not Available
Congenital genital malformation21.15.02.001; 03.03.02.0020.001859%Not Available
The 10th Page    First    Pre   10 11    Next   Last    Total 11 Pages